Dilazep, an antiplatelet agent, inhibits tissue factor expression in endothelial cells and monocytes

Blood

Volumn 90, Issue 6, 1997, Pages 2345-2356

  Deguchi, Hiroshi ^a   Takeya, Hiroyuki ^a   Wada, Hideo ^a   Gabazza, Esteban C ^a   Hayashi, Nobuyuki ^a   Urano, Hajime ^a   Suzuki, Koji ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR STIMULATING AGENT; ANTITHROMBOCYTIC AGENT; DILAZEP; PHORBOL 13 ACETATE 12 MYRISTATE; THROMBIN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR;

ANTIGEN EXPRESSION; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; HYPERCOAGULABILITY; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030770061     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.6.2345.2345_2345_2356     Document Type: Article

References (53)

1. Nemerson Y: Tissue factor and hemostasis. Blood 71:1, 1988
2. Miller CL, Graziano C, Lim RC, Chin M: Generation of tissue factor by patient monocytes: Correlation to thromboembolic complications. Thromb Haemost 46:489, 1981
3. Rickles FR, Hair GA, Zeff RA, Lee E, Bona R: Tissue factor expression in human leukocytes and tumor cells. Thromb Haemost 74:391, 1995
4. Wada H, Wakita Y, Shiku H: Tissue factor expression in endothelial cells in health and disease. Blood Coag Fibrinol 6:526, 1995
5. Galdal KS, Lyberg T, Evensen SA, Nilsen E, Prydz H: Thrombin induces thromboplastin synthesis in cultured vascular endothelial cells. Thromb Haemost 54:373, 1985
6. Scarpati EM, Sadler JE: Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J Biol Chem 264:20705, 1989
7. Archipoff G, Beretz A, Freyssinet JM, Soyer CK, Brisson C, Cazenave JP: Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumor necrosis factor, thrombin or phorbol ester. Biochem J 273:679, 1991
8. Herbert JM, Savi P, Laplace MC, Lale A: IL-4 inhibits LPS-, IL-1 beta-and TNF alpha-induced expression of tissue factor in endothelial cells and monocytes. FEBS Lett 310:31, 1992
9. Martin NB, Jamieson A, Tuffin DP: The effect of interleukin-4 on tumor necrosis factor-alpha induced expression of tissue factor and plasminogen activator inhibitor-1 in human umbilical vein endothelial cells. Thromb Haemost 70:1037, 1993
10. Herbert JM, Savi P, Laplace MC, Lale A, Dol F, Dumas A, Labit C, Minty A: IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes. FEBS Lett 328:268, 1993
11. Ishii H, Horie S, Kizaki K, Kazama M: Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor. Blood 80:2556, 1992
12. Archipoff G, Beretz A, Bartha K, Brisson C, de la Salle C, Froget-Léon C, Klein-Soyer C, Cazenave JP: Role of cyclic AMP in promoting the thromboresistance of human endothelial cells by enhancing thrombomodulin and decreasing tissue factor activities. Br J Pharmacol 109:18, 1993
13. Perosi G, Levantesi D, Trivella MG, Marzilli M: Effect of dilazep on coronary and systemic circulation. Pharmacology 31:82, 1985
14. Yoshida H, Kanatsu K, Muso E, Kuwahara T, Sekita K, Ono T, Konishi N, Kanda C, Minakata T, Morimoto K, Takemura S, Umeda Y, Suzuki T, Shu Y-S, Takashima K, Tamura T: Effects of an anti-platelet drug (dilazep) in IgA nephropathy: Comparison of clinical effects with renal biopsy findings. Jpn J Nephrol 36:339, 1994
15. Mustafa SJ, Nakagawa Y: Relaxing effects of dilazep and lidoflazine in dog cerebral and renal arteries independent of adenosine. Pharmacology 37:75, 1988
16. Zhang Y, Legare D, Geiger J, Lautt W: Dilazep potentiation of adenosine-mediated superior mesenteric arterial vasodilation. J Pharmacol Exp Ther 258:767, 1991
17. Tanabe S, Tamaki T, Wada Y, Sumiyoshi A, Funahara Y: Cytoprotective effect of dilazep on hydrogen peroxide perturbed vascular endothelial cells. Southeast Asian J Trop Med Public Health 23:120, 1992
18. Takimoto M, Asanuma A, Fujii M, Tanaka M, Nobuyoshi M: Thrombus formation on the aorta injured by angioplasty and its prevention with dilazep in atherosclerotic rabbits. Thromb Res 54:561, 1989
19. Kurachi K, Schmer G, Hermodson MA, Teller DC, Davie EW: Characterization of human, bovine and horse antithrombin III. Biochemistry 15:368, 1976
20. Suzuki K, Stenflo J, Dahlbäck B, Teodorssen B: Inactivation of human coagulation factor V by activated protein C. J Biol Chem 258:1914, 1980
21. Deguchi H, Takeya H, Gabazza EC, Nishioka J, Suzuki K: Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrombinase complex. Biochem J 321:729, 1997
22. Wada H, Mori Y, Kaneko T, Wakita Y, Nakase T, Minamikawa K, Ohiwa M, Tamaki S, Tanigawa M, Kageyama S, Deguchi K, Nakano T, Shirakawa S, Suzuki K: Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia. Am J Hematol 44:112, 1993
23. Ito T, Hiraiwa J, Nishioka J, Iino M, Suzuki K: Characterization of functionally important regions of tissue factor by using monoclonal antibodies. J Biochem 114:691, 1993
24. Moldow CF, Bach RR, Staskus K, Rick PD: Induction of endothelial tissue factor by endotoxin and its precursors. Thromb Haemost 70:702, 1993
25. Brisseau GF, Dackiw AP, Cheung PY, Christie N, Rotstein OD: Posttranscriptional regulation of macrophage tissue factor expression by antioxidants. Blood 85:1025, 1995
26. Orthner CL, Rodgers GM, Fitzgerald LA: Pyrrolidine dithiocarbamate abrogates tissue factor (TF) expression by endothelial cells: Evidence implicating nuclear factor-κB in TF induction by diverse agonists. Blood 86:436, 1995
27. Pötgens AJ, Lubsen NH, van Altena G, Schoenmakers JG, Ruiter DJ, de Waal R: Measurement of tissue factor messenger RNA levels in human endothelial cells by a quantitative RT-PCR assay. Thromb Haemost 71:208, 1994
28. Scarpati EM, Wen D, Broze JGJ, Miletich JP, Flandermeyer RR, Siegel NR, Sadler JE: Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry 26:5234, 1987
29. Hayashi T, Honda G, Suzuki K: An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin expression in human umbilical vein endothelial cells. Blood 79:2930, 1992
30. Crutchley DJ, Hirsh MJ: The stable prostacyclin analog, iloprast, and prostaglandine E1 inhibit monocyte procoagulant activity in vitro. Blood 78:382, 1991
31. Pearson JD, Carleton JS, Hutchings A, Gordon JL: Uptake and metabolism of adenosine by pig aortic endothelial and smooth-muscle cells in culture. Biochem J 170:265, 1978
32. Schäumlöffel E, Prignitz R: Isotope-technical studies on pharmacokinetics and metabolism of dilazep in man. Drug Res 22:1651, 1972
33. McCann W, Katholi R: Control of artifacts in plasma adenosine determination. Proc Soc Exp Biol Med 185:93, 1990
34. Zhang Y, Geiger J, Legare D, Lautt W: Dilazep-induced vasodilation is mediated through adenosine receptors. Life Sci 49:129, 1991
35. Wilcox JN, Smith KM, Schwartz SM, Gordon D: Localization of tissue factor in normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 86:964, 1989
36. Edwards RL, Levine JB, Green R, Duffy M, Mathews E, Brande W, Rickles FR: Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity. Gastroenterology 92:329, 1987
37. Francis J, Carvalho M, Francis D: The clinical value of tissue factor assays. Blood Coag Fibrinol 6:S37, 1995
38. Crossman DC, Carr DP, Tuddenham EGD, Pearson JD, McVey JH: The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem 265:9782, 1990
39. Ahern SM, Miyata T, Sadler JE: Regulation of human tissue factor expression by mRNA turnover. J Biol Chem 268:2154, 1993
40. Kruse HJ, Mayerhofer C, Siess W, Weber PC: Thrombin receptor-activating peptide sensitizes the human endothelial thrombin receptor. Am J Physiol 268:C36, 1995
41. Brass LF: Issues in the development of thrombin receptor antagonists. Thromb Haemost 74:499, 1995
42. Wiegmann K, Schütze S, Machleidt T, Witte D, Krönke M: Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78:1005, 1994
43. Deisher T, Haddix T, Montgomery K, Pohlman T, Kaushansky K, Harlan J: The role of protein kinase C in the induction of VCAM-1 expression on human umbilical vein endothelial cells. FEBS Lett 331:285, 1993
44. Ritchie A, Johnson D, Ewenstein B, Pober J: Tumor necrosis factor induction of endothelial cell surface antigens is independent of protein kinase C activation or inactivation. J Immunol 146:3056, 1991
45. Malter JS, Hong Y: A redox switch and phosphorylation are involved in the post-transcriptional up-regulation of the adenosine-uridine binding factor by phorbol ester and ionophore. J Biol Chem 266:3167, 1991
46. Hentze MW, Rouault TA, Harford JB, Klausner RD: Oxidation-reduction and the molecular mechanism of a regulatory RNA-protein interaction. Science 244:357, 1989
47. Young J, Kane LP, Exley M, Wileman T: Regulation of selective protein degradation in the endoplasmic reticulum by redox potential. J Biol Chem 268:19810, 1993
48. Hwang C, Sinskey AJ, Lodish HF: Oxidized redox state of glutathione in the endoplasmic reticulum. Science 257:1496, 1992
49. Braakman I, Helenius J, Helenius A: Manipulating disulfide bond formation and protein folding in the endoplasmic reticulum. EMBO J 11:1717, 1992
50. Lentz SR, Sadler JE: Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum. Blood 81:683, 1993
51. Kornfeld RÅ, Kornfeld S: Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54:631, 1991
52. Brand K, Page S, Rogler G, Bartsch A, Brandi R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D: Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 97:1715, 1996
53. Bearman SI: The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 85:3005, 1995